Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study

Lenalidomide maintenance therapy prolonged progression‐free survival (PFS) versus placebo in elderly patients with diffuse large B‐cell lymphoma (DLBCL) responding to induction chemotherapy in the phase 3 REMARC study. This subpopulation analysis assessed the impact of lenalidomide maintenance and t...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Br J Haematol
Huvudupphovsmän: Thieblemont, Catherine, Howlett, Susannah, Casasnovas, René‐Olivier, Mounier, Nicolas, Perrot, Aurore, Morschhauser, Franck, Fruchart, Christophe, Daguindau, Nicolas, van Eygen, Koen, Obéric, Lucie, Bouabdallah, Reda, Pica, Gian Matteo, Nicolas‐Virezelier, Emmanuelle, Abraham, Julie, Fitoussi, Olivier, Snauwaert, Sylvia, Eisenmann, Jean‐Claude, Lionne‐Huyghe, Pauline, Bron, Dominique, Tricot, Sabine, Deeren, Dries, Gonzalez, Hugo, Costello, Régis, Le Du, Katell, da Silva, Maria Gomes, Grosicki, Sebastian, Trotman, Judith, Catalano, John, Caballero, Dolores, Greil, Richard, Cohen, Amos M., Gaulard, Philippe, Roulin, Louise, Takeshita, Kenichi, Casadebaig, Marie‐Laure, Tilly, Hervé, Coiffier, Bertrand
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2019
Ämnen:
Haematological Malignancy ‐ Clinical
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7154674/
https://ncbi.nlm.nih.gov/pubmed/31702836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.16300
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk